Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bal Pharma Ltd

BALPHARMA.NS ✗ NOT COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.91

▼ -1.35%

Market Cap $14.52M · Vol 16.23K

Key Metrics

P/E Ratio

19.17

FWD: N/A

Market Cap

$14.52M

Micro Cap

Div Yield

1.38%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

46.62

Momentum

Beta

1.05

vs Market

52W High

$1.04

15.00% below

52W Low

$0.63

43.43% above

Volume

16.23K

Avg 52.31K

P/B

1.17

Price-to-book

ROE

N/A

Return on equity

Free Float

34.72%

Public shares

Shariah Compliance8 STANDARDS

✗ Bal Pharma Ltd (BALPHARMA.NS) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BALPHARMA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.44%

-4.36%

+10.26%

+15.74%

YTD

+18.73%

-0.90%

-19.90%

-15.81%

Financials & Valuation

TTM · Annual

Total Revenue	$33.35M
Net Income	$676.25K
Revenue Growth (YoY)	+34.53%
Gross Margin	45.76%
Operating Margin	6.68%
Net Profit Margin	2.03%
ROE	N/A
ROA · ROIC	1.67% · 10.31%

P/E Ratio	19.17
Forward P/E (FY1)	N/A
PEG Ratio	-1.16
P/S	0.31
P/B	1.17
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	15.92M

Technical Indicators

50-Day SMA	$0.90
200-Day SMA	$0.82
RSI (14)	46.62
Beta	1.05
52-Week High	$1.04
52-Week Low	$0.63

Volume Today	16.23K
Avg Daily Volume (30D)	52.31K
Relative Volume	0.31x
Volatility (10D)	40.94
Volatility (30D)	52.01
Free Float	34.72%

Analyst Consensus

N/A

Current Price $0.91

Mean Target N/A

52W Low$0.63 52W High$1.04

Current

Target

$0.63 $1.04

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S7J2S6

ISININE083D01012

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.